CASE STUDY: PHASE 3 FDA & MHRA PRE-INSPECTION READINESS

CASE STUDY: Phase 3 FDA & MHRA Pre-Inspection Readiness

Download Case Study

• The Situation A small global pharmaceutical company had planned to use their internal QA staff to perform various types of GCP audits for a Phase 3 project in preparation for FDA and MHRA submissions
  However, as deadlines approached and priorities shifted for staff, the company fell behind in its preparation process. Subsequently, they began searching for a nimble and reliable GCP auditing provider with global outreach to perform inspection readiness audits within a tight timeline. FDA/MHRA inspection readiness audits ensure that sites/vendors have complied with applicable regulations, SOPs, working procedures, systems, processes, and identification of potential pitfalls.
• The Response Projects with aggressive timelines can be fraught with execution and quality risks
  To limit those risks, ClinAudits provided this client a solution that leveraged ClinAudits extensive global network of auditors to complete 29 audits in 12 countries within 2.5 months. A project manager worked closely with client management providing flexibility and responsiveness as the scope and number of audits evolved during this engagement. Following the completion of each audit, ClinAudits peer reviewers ensured all deliverables met internal quality standards and ClinAudits provided ongoing metric reports.
• The Results By leveraging proprietary SOPs and metric tools, ClinAudits was able to provide both effective and efficient auditing services as well as robust metrics on audit trends from generated audit reports.
  ClinAudits’ global network of seasoned auditors, combined with the dedication of project management and its streamlined auditing process, ensured the completion of this assignment within the required timeframe. ClinAudits continues to serve as a trusted partner for this client.
• ClinAudits Advantages
  • FDA/MHRA inspection readiness audits conducted by a third party are particularly beneficial to clients that lack the capacity or expertise to conduct an audit themselves or desire an unbiased audit.
  • ClinAudits is an independent global auditing firm that examines a client’s current GCP processes with a critical lens and prepares clients for future FDA/EMEA or other regulatory agency inspections. In this case, ClinAudits conducted 21 investigator site audits, 2 PV audits, 2 mock FDA/EMEA sponsor audits and 4 document audits for the client.
  • ClinAudits’ auditors have an average of 26 years of industry and 18 years of GxP auditing experience. As a result, ClinAudits is a leader in the quality assurance field.
  • Among surveyed clients, respondents indicated that ClinAudits’ auditor experience was its most valuable resource.¹
  • ClinAudits’ auditors are well versed in industry leading practices and are subject matter experts in their particular auditing fields.

  “Rising capacity demands combined with a difficult global operating environment are pressuring sponsors to derive ever-higher levels of performance and efficiency in their outsourcing relationships. The growing prevalence of a functional service provider and alliance relationships holds the promise of delivering decreased operating expenses…and increased operating flexibility” ²

  ¹ Rutgers Consulting Team, 2014 Survey of ClinAudits Clients
  ² Vogel, J. and Getz, K. “Successful Outsourcing: Tracking Global CRO Usage”. Applied Clinical Trials. 17 Aug 2009. Web.